SearchDictionaryMobileLogin

Evaluation of a commercial staphylococcal bacterin for management of idiopathic recurrent superficial pyoderma in dogs.

AbstractTwenty-one dogs with idiopathic superficial recurrent pyoderma were entered into a double-blind, placebo-controlled study to evaluate the efficacy of a commercial staphylococcal bacterin. The study spanned an 18-week period. All dogs were administered sodium oxacillin orally for the initial 6 weeks of the study. Dogs were given the bacterin or placebo SC, twice weekly at 3- or 4-day intervals, beginning at week 0 and continuing for 18 weeks. Dogs given antibiotics plus the bacterin (n = 13) had a significantly (P less than 0.05) better treatment response than those given antibiotic plus placebo.
AuthorsD J DeBoer, K A Moriello, C B Thomas, K T Schultz (Affiliation: Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin-Madison 53706.)
JournalAmerican journal of veterinary research (Am J Vet Res) Vol. 51 Issue 4 Pg. 636-9 (Apr 1990) ISSN: 0002-9645 UNITED STATES
PMID2327626 (Publication Type: Journal Article)
Chemical References
  • Staphylococcal Vaccines
  • Oxacillin
Topics
  • Animals
  • Dog Diseases (drug therapy)
  • Dogs
  • Double-Blind Method
  • Injections, Subcutaneous
  • Oxacillin (therapeutic use)
  • Pyoderma (drug therapy, veterinary)
  • Recurrence
  • Staphylococcal Vaccines (administration & dosage, therapeutic use)
  • Time Factors